| Notifications | Preventive Care Services | 00.06.02ar | 6/1/2024 10:00 AM | 7/1/2024 | | | 6/1/2024 | Medical Necessity Criteria;Medical Coding | | |
| Notifications | Surgical Procedures of the Eyelid and Brow | 11.05.02k | 6/18/2024 11:00 AM | 9/16/2024 | | | 6/18/2024 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Risankizumab-rzaa (Skyrizi®) for Intravenous Use | 08.01.95b | | 6/3/2024 | | | 6/3/2024 | Medical Coding | | |
| Updated Policies | Reimbursement for the Administration of Immunizations | 07.00.15n | | 6/3/2024 | | | 6/3/2024 | Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Not Medically Necessary Services and Obsolete or Unreliable Diagnostic Tests | 00.01.24k | | 6/3/2024 | | | 6/3/2024 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Reduction Mammoplasty | 11.08.02l | | 6/3/2024 | | | 6/3/2024 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Tafasitamab-cxix (Monjuvi®) | 08.01.81c | | 6/3/2024 | | | 6/3/2024 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Biofeedback Therapy | 07.00.01m | | 4/1/2024 | | | 6/17/2024 | Medical Coding | | |
| Updated Policies | Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane® for Injectable Suspension) | 08.00.90q | | 6/17/2024 | | | 6/17/2024 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Solid Organ Transplantation and Procurement Cost of Organs and Tissues | 11.00.09g | | 6/17/2024 | | | 6/17/2024 | Coverage and/or Reimbursement Position | | |
| Updated Policies | Anifrolumab-fnia (Saphnelo®) | 08.01.82c | | 6/17/2024 | | | 6/17/2024 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Cataract Surgery | 11.01.07g | | 6/17/2024 | | | 6/17/2024 | Medical Coding | | |
| Updated Policies | Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) Monitoring | 07.02.21p | 3/22/2024 11:00 AM | 6/24/2024 | | | 6/24/2024 | Medical Coding | | |
| Reissue Policies | Anesthesia Services for Epidural, Paravertebral Facet and Sacroiliac Joint Injections for Spinal Joint Management | 01.00.12b | | 10/1/2023 | 6/12/2024 | | 6/12/2024 | | | |
| Reissue Policies | Surgery for Gynecomastia | 11.08.12i | | 1/1/2024 | 6/12/2024 | | 6/12/2024 | | | |
| Reissue Policies | Home-Use Light Box for the Treatment of Seasonal Affective Disorder (SAD) | 05.00.69c | | 1/1/2023 | 6/12/2024 | | 6/12/2024 | | | |
| Reissue Policies | Photodynamic Therapy (PDT) Using Verteporfin (Visudyne®) | 07.13.05k | | 5/7/2018 | 6/12/2024 | | 6/12/2024 | | | |
| Reissue Policies | Smell and Taste Dysfunction Testing | 07.11.01c | | 5/7/2018 | 6/12/2024 | | 6/12/2024 | | | |
| Reissue Policies | Cranial Electrotherapy Stimulation | 05.00.80d | | 1/1/2024 | 6/12/2024 | | 6/12/2024 | | | |
| Reissue Policies | Photodynamic Therapy (PDT) Using Levulan® Kerastick® or Ameluz® (Aminolevulinic Acid HCl [ALA]) | 07.07.03m | | 7/1/2019 | 6/12/2024 | | 6/13/2024 | | | 6/13/2024 |
| Reissue Policies | Photodynamic Therapy (PDT) Using Levulan® Kerastick® or Ameluz® (Aminolevulinic Acid HCl [ALA]) | 07.07.03m | | 7/1/2019 | 6/12/2024 | | 6/13/2024 | | | |
| Reissue Policies | Therapeutic Drug Monitoring for Antidepressants, Antipsychotics, or Antiepileptics | 06.02.55a | | 1/1/2023 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Never Events and Preventable Serious Adverse Events | 00.01.44j | | 12/5/2022 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Photocoagulation of Macular Drusen | 11.05.08d | | 6/14/2017 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Injectable Dermal Fillers for Cosmetic Procedures | 05.00.62i | | 7/1/2023 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Surgical Correction of Strabismus | 11.05.07d | | 9/7/2016 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | X-rays Associated with Fractures in the Office Setting | 00.03.09f | | 12/5/2022 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Magnetic Resonance Imaging (MRI)-Guided Focused Ultrasound Ablation | 11.06.06g | | 8/29/2022 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Laparoscopic, Percutaneous, and Transcervical Techniques for Uterine Fibroid Myolysis | 11.06.10a | | 1/1/2024 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Guidelines for Home Care Visits Following Inpatient Maternity Stay | 00.05.01g | | 10/25/2021 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Radiologic Guidance and/or Supervision and Interpretation of a Procedure | 00.10.36u | | 8/1/2022 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Full-Body Monoplace or Multiplace Chamber Hyperbaric Oxygen Therapy | 07.00.03p | | 11/15/2023 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Air Ambulance Services | 12.04.03c | | 1/1/2019 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Laboratory-Based Vestibular Function Testing | 07.03.24b | | 1/1/2021 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Hospice Care | 02.02.01h | | 12/6/2021 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Corneal Pachymetry Using Ultrasound | 07.13.07l | | 9/19/2022 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Noncontraceptive Use of the Levonorgestrel-Releasing Intrauterine System | 07.10.05n | | 1/2/2024 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | First-Trimester Prenatal Screening for Fetal Aneuploidy Using Fetal Ultrasound Markers | 09.00.36m | | 11/21/2022 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Reimbursement for an Intraocular Lens | 11.05.10c | | 1/18/2021 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Refractive Keratoplasty | 11.05.01g | | 7/1/2022 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Topical Oxygenation | 07.00.09d | | 4/8/2015 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Sentinel Lymph Node Biopsy and Mapping | 11.07.02k | | 1/1/2023 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Presumptive and Definitive Drug Testing in Substance Abuse and Pain Management Treatments | 06.02.44q | | 7/1/2023 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Delandistrogene moxeparvovec (delandistrogene moxeparvovec-rokl; Elevidys®) | 08.02.13 | | 1/10/2024 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Elivaldogene Autotemcel [eli-cel (Skysona®)] | 08.01.92 | | 5/22/2023 | 6/26/2024 | | 6/26/2024 | | | |
| Coding Update | Beremagene Geperpavec (Vyjuvek™) | 08.02.10a | | 1/1/2024 | | | 6/3/2024 | | | |
| Coding Update | Valoctocogene roxaparvovec-rvox (ROCTAVIAN™) | 08.02.09a | | 1/1/2024 | | | 6/3/2024 | | | |
| Coding Update | Microprocessor-Controlled Prostheses for Lower-Extremity Amputees | 11.14.21j | | 1/1/2024 | | | 6/25/2024 | | | |
| Archived Policies | Medical Evaluation and Management for Attention-Deficit Hyperactivity Disorder (ADHD) | 07.03.03h | 6/14/2024 8:00 AM | 7/15/2024 | | | 6/14/2024 | | | |